The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for P Alfonso


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of ETP-46321, a potent and orally bioavailable PI3Ka,d inhibitor.EBI
Spanish National Cancer Research Centre (Cnio)
Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.EBI
Spanish National Cancer Research Centre (Cnio)
Imidazo[1,2-a]pyrazines as novel PI3K inhibitors.EBI
Spanish National Cancer Research Centre (Cnio)
Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy.EBI
Stony Brook University
Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases.EBI
Perha Pharmaceuticals
Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy.EBI
Spanish National Cancer Research Centre (Cnio)